Zhenlin Yang

1.1k total citations
35 papers, 723 citations indexed

About

Zhenlin Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhenlin Yang has authored 35 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Zhenlin Yang's work include MicroRNA in disease regulation (11 papers), RNA Interference and Gene Delivery (6 papers) and Cancer-related molecular mechanisms research (6 papers). Zhenlin Yang is often cited by papers focused on MicroRNA in disease regulation (11 papers), RNA Interference and Gene Delivery (6 papers) and Cancer-related molecular mechanisms research (6 papers). Zhenlin Yang collaborates with scholars based in China and Australia. Zhenlin Yang's co-authors include Kai Cheng, Xiaohong Wang, Guoqiang Zhang, Yong Han, Guoqiang Zhang, Jianli Dong, Xiaohong Wang, Guanghe Cui, Jie He and Yibo Gao and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Signal Transduction and Targeted Therapy.

In The Last Decade

Zhenlin Yang

34 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenlin Yang China 15 517 357 106 69 66 35 723
Jing Ding China 15 588 1.1× 337 0.9× 105 1.0× 72 1.0× 72 1.1× 37 844
Anuradha Kirtonia India 10 563 1.1× 284 0.8× 173 1.6× 71 1.0× 106 1.6× 12 904
Chandan Kanta Das India 13 486 0.9× 236 0.7× 157 1.5× 54 0.8× 57 0.9× 20 816
Valentina Pileczki Romania 15 414 0.8× 267 0.7× 125 1.2× 49 0.7× 46 0.7× 27 666
Joseph W. Fischer United States 9 663 1.3× 387 1.1× 141 1.3× 64 0.9× 53 0.8× 12 998
Zaiming Lu China 15 477 0.9× 277 0.8× 109 1.0× 51 0.7× 72 1.1× 25 666
Yinghui Huang China 18 881 1.7× 360 1.0× 205 1.9× 83 1.2× 82 1.2× 44 1.2k
Chuangyu Wen China 18 506 1.0× 279 0.8× 113 1.1× 63 0.9× 63 1.0× 34 752

Countries citing papers authored by Zhenlin Yang

Since Specialization
Citations

This map shows the geographic impact of Zhenlin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlin Yang more than expected).

Fields of papers citing papers by Zhenlin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenlin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlin Yang. The network helps show where Zhenlin Yang may publish in the future.

Co-authorship network of co-authors of Zhenlin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenlin Yang. A scholar is included among the top collaborators of Zhenlin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenlin Yang. Zhenlin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fei, Yongjiu Wang, Zhenlin Yang, et al.. (2025). Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study. Signal Transduction and Targeted Therapy. 10(1). 45–45. 1 indexed citations
2.
Yang, Zhenlin, et al.. (2025). The miR-34a-5p Promotes Hippocampal Neuronal Ferroptosis in Epilepsy by Regulating SIRT1. Neurochemical Research. 50(2). 124–124. 2 indexed citations
3.
Cheng, Li‐Hao, et al.. (2024). Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism. The FASEB Journal. 38(5). e23550–e23550. 6 indexed citations
4.
Yang, Zhenlin, et al.. (2024). SIMCB-Yolo: An Efficient Multi-Scale Network for Detecting Forest Fire Smoke. Forests. 15(7). 1137–1137. 11 indexed citations
5.
Li, Xiao, Kai Cheng, Yong Yang, et al.. (2024). MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1. BMC Cancer. 24(1). 902–902. 1 indexed citations
6.
Zhang, Haojie, Xiangsheng Zhang, Xiaohong Wang, et al.. (2022). Comprehensive Analysis of TRP Channel–Related Genes in Patients With Triple-Negative Breast Cancer for Guiding Prognostic Prediction. Frontiers in Oncology. 12. 941283–941283. 6 indexed citations
7.
8.
Wang, Song, et al.. (2021). Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study. Frontiers in Oncology. 11. 783631–783631. 3 indexed citations
9.
10.
Wang, Xiaohong, Kai Cheng, Guoqiang Zhang, et al.. (2020). Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance. Frontiers in Oncology. 10. 960–960. 43 indexed citations
11.
Wang, Xiaohong, Kai Cheng, Yingzhe Zhang, et al.. (2018). Psoralen induced cell cycle arrest by modulating Wnt/β-catenin pathway in breast cancer cells. Scientific Reports. 8(1). 14001–14001. 35 indexed citations
12.
Zou, Weiwei, Yu Bai, Xilong Wang, et al.. (2017). PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 32(8). 282–287. 6 indexed citations
13.
Wang, Xilong, et al.. (2017). Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs. Archives of Gynecology and Obstetrics. 296(3). 543–549. 4 indexed citations
14.
Guo, Wei, Yibo Gao, Ning Li, et al.. (2017). Exosomes: New players in cancer. Oncology Reports. 38(2). 665–675. 123 indexed citations
15.
Wang, Xiaohong, Leitao Sun, Kai Cheng, et al.. (2016). Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 186–186. 65 indexed citations
16.
Wang, Xiaohong, et al.. (2016). Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Molecular Medicine Reports. 13(6). 4745–4750. 36 indexed citations
17.
Liu, Song, Fan Zhang, Jun Niu, et al.. (2016). Tumor specific delivery and therapy mediate by integrin β6-target immunoliposomes for β6-siRNA in colon carcinoma. Oncotarget. 7(51). 85163–85175. 13 indexed citations
18.
Han, Yong, et al.. (2015). miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. Human Cell. 29(1). 30–36. 23 indexed citations
19.
Zhang, Guoqiang, et al.. (2014). MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells. Tumor Biology. 35(11). 11137–11145. 74 indexed citations
20.
Zhang, Hao, et al.. (2004). Lymphotactin enhances the in-vitro immune efficacy of dendritoma formed by dendritic cells and mouse hepatocellular carcinoma cells. Journal of Zhejiang University. Science A. 5(10). 1255–1261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Ding Breakdown of academic impact, for papers by Anuradha Kirtonia Breakdown of academic impact, for papers by Chandan Kanta Das Breakdown of academic impact, for papers by Valentina Pileczki Breakdown of academic impact, for papers by Joseph W. Fischer Breakdown of academic impact, for papers by Zaiming Lu Breakdown of academic impact, for papers by Yinghui Huang Breakdown of academic impact, for papers by Chuangyu Wen
Rankless by CCL
2026